Glaucoma is a disease that harms the optic nerve—the part of the eye that sends images to the brain. It usually has no warning signs in the beginning and can slowly cause vision loss. Many people ...

A Eureka eye center that treats hundreds of patients a week is set to close in February, sparking concern over an upcoming shrinkage of doctors who perform specialist eye treatments and surgeries ...

Through 24 months, scleral bio-reinforced cyclodialysis combined with cataract surgery lowered IOP by enhancing uveoscleral ...

This growth was powered by sales of its foundational glaucoma products.

University of Eastern Finland has synthesized carbonic anhydrase II (CA2) inhibitors and melanin ligands. As such, they are described as potentially useful for the treatment of glaucoma, macular edema ...

A home tonometer is effective for detecting diurnal fluctuations and out-of-office intraocular pressure spikes for patients at glaucoma risk.

U.S. Glaucoma net sales reached $80.8 million, with iDose TR contributing approximately $40 million. International Glaucoma net sales were $29.4 million, and Corneal Health franchise net sales totaled ...

Q3 2025 Earnings Call October 29, 2025 4:30 PM EDTCompany ParticipantsChristopher Lewis - Vice President of Investor ...

From MIGS integration to remote monitoring and next-generation therapeutics, glaucoma specialists explore how new approaches ...

Q. I stopped glucosamine when I found that it can increase eye pressure in glaucoma. My cholesterol on my next checkup a year later was 150. I always was around 210 before then. Now I wonder if the ...

Sight Sciences, Inc. (($SGHT)) announced an update on their ongoing clinical study. Study Overview: Sight Sciences, Inc. is conducting a pilot ...

Nova Eye Medical Ltd (($ELXMF)) announced an update on their ongoing clinical study. Study Overview: Nova Eye Medical Ltd is conducting a clinical ...